Lunai Bioworks Inc. Common Stock (LNAI) Stock Price

LNAIStock

$0.68−93.03%52W

Market Cap$3.08M

P/E—

PEG Ratio—

Div yield—

Beta0.36

LNAI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-84.80%

Price vs S&P 500 (4W)-69.09%

VGM Score6.03

Book Value / Share (Quarterly)$5.44

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.15

Price vs S&P 500 (YTD)-102.28%

Net Profit Margin (TTM)-8813.41%

EPS (TTM)$-0.88

10-Day Avg Trading Volume0.13M

EPS Excl Extra (TTM)$-0.88

EPS (Annual)$-1.06

ROI (Annual)-65.78%

Gross Margin (Annual)100.00%

Cash / Share (Quarterly)$0.37

ROA (Last FY)-35.83%

EBITD / Share (TTM)$-1.19

ROE (5Y Avg)-66.15%

Operating Margin (TTM)-8948.41%

Cash Flow / Share (Annual)$-1.15

P/B Ratio0.04x

P/B Ratio (Quarterly)1.00x

Net Income / Employee (Annual)$-122,800

Net Interest Coverage (TTM)-60.36x

ROA (TTM)-42.63%

EPS Incl Extra (Annual)$-1.06

Current Ratio (Annual)0.11x

Quick Ratio (Quarterly)0.09x

3-Month Avg Trading Volume0.69M

52-Week Price Return-93.03%

Revenue / Employee (TTM)$1,800

Tangible BV / Share (Quarterly)$5.44

P/S Ratio (Annual)65.89x

Asset Turnover (Annual)0.01x

52-Week High$13.28

EPS Excl Extra (Annual)$-1.06

CapEx CAGR (5Y)-52.26%

26-Week Price Return-74.89%

Quick Ratio (Annual)0.09x

13-Week Price Return-75.87%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)0.11x

Enterprise Value$2.70M

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$1,800

Pretax Margin (Annual)-6852.24%

Cash / Share (Annual)$0.37

3-Month Return Std Dev103.12%

Net Income / Employee (TTM)$-122,800

ROE (Last FY)-67.00%

Net Interest Coverage (Annual)-174.36x

EPS Basic Excl Extra (Annual)$-1.06

Total Debt / Equity (Quarterly)0.07x

EPS Incl Extra (TTM)$-0.88

ROI (TTM)-64.39%

P/S Ratio (TTM)65.89x

Revenue / Share (Annual)$0.02

Price vs S&P 500 (52W)-108.56%

Year-to-Date Return-90.35%

5-Day Price Return-38.70%

EPS Normalized (Annual)$-1.06

ROA (5Y Avg)-490.97%

Net Profit Margin (Annual)-6852.24%

Month-to-Date Return-53.71%

EBITD / Share (Annual)$-1.19

Operating Margin (Annual)-7875.40%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-61.91%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.88

P/TBV (Quarterly)1.00x

Pretax Margin (TTM)-8813.41%

Price vs S&P 500 (13W)-78.56%

Beta0.36x

Revenue / Share (TTM)$0.01

ROE (TTM)-67.00%

52-Week Low$0.66

mGradeF

vgmGradeF

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
LNAILunai Bioworks Inc. Common Stock	—	—	F	65.9x	—	—	—	$0.68
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Lunai Bioworks Inc. Common Stock

Lunai Bioworks is a biopharmaceutical company developing allogeneic cell and gene therapies designed to enhance immune responses and potentially achieve long-term cancer remission. The company's pipeline includes cell therapeutic vaccine candidates RENB-DC11 and RENB-DC20, supported by proprietary AI diagnostics and machine learning platforms that analyze genetic data for earlier cancer detection and clinical insights. Lunai operates through three segments (RENB, BioSymetrics, and RENC) with operations in the United States and Netherlands.